Insights from 2023 SABCS

 

Insights from 2023 SABCS
J

SABCS 2023 Insights: "Evaluating Low-Dose vs. Standard-Dose Olanzapine With Triple Antiemetic Therapy for Prevention of Highly Emetogenic Chemo-Induced Nausea & Vomiting in Solid Tumors"

By Insights from 2023 SABCS FEATURING Jyoti Bajpai
By Insights from 2023 SABCS FEATURING Jyoti Bajpai
59 views
February 28, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy
Videos
20:25

SABCS 2023 Insights: "Optimizing Adjuvant Endocrine Therapy for Prem…

Insights from 2023 SABCS

V. Stearns

458 views
08:23

SABCS 2023 Insights: "Evaluating Low-Dose vs. Standard-Dose Olanzapi…

Insights from 2023 SABCS

J. Bajpai

59 views
12:21

SABCS 2023 Insights: "How to Treat TNBC"

Insights from 2023 SABCS

P. Sharma

593 views
23:33

SABCS 2023 Insights: "The Role for Dato-DXd in HR+ mBC"

Insights from 2023 SABCS

S. Tolaney, H. Rugo

396 views
26:30

SABCS 2023 Summary: "HER2+ BC Highlights From KATHERINE & HER2CLIMB-…

Insights from 2023 SABCS

S. Tolaney, H. Rugo

413 views
13:33

SABCS 2023 Insights: "PREFERABLE-EFFECT Study - Effects of a Structu…

Insights from 2023 SABCS

A. Hiensch

61 views
08:07

SABCS 2023 Insights: "Protocol-Defined Biomarker Analysis in the PAL…

Insights from 2023 SABCS

D. Stover

54 views
17:18

SABCS 2023 Insights: "ELECTRA Study of Elacestrant in Combination Wi…

Insights from 2023 SABCS

N. Ibrahim

236 views
27:52

SABCS 2023 Insights: "Innovative Approaches at the Diagnosis and Tre…

Insights from 2023 SABCS

J. Mouabbi

255 views
09:41

SABCS 2023 Insights: "ADAPTcycle Trial - Impact of Age and Ovarian F…

Insights from 2023 SABCS

O. Gluz

818 views
29:40

Year in Review: Metastatic Breast Cancer

Insights from 2023 SABCS

M. Mac Gregor

942 views
10:14

SABCS 2023 Insights: "A Study of RGT-419B, a Next-Gen CDK4 Inhibitor…

Insights from 2023 SABCS

S. Wander

165 views
04:30

SABCS 2023 Insights: "VERITAC-3 Study, With a Lead-in, of 1L Vepdege…

Insights from 2023 SABCS

S. Wander

178 views
14:00

SABCS 2023 Insights: "CDK4/6 Inhibition as a Potential Vulnerability…

Insights from 2023 SABCS

E. Chang

90 views
08:45

SABCS 2023 Insights: "OPERA-01 Study of Palazestrant vs. Standard-of…

Insights from 2023 SABCS

A. Chan

94 views
11:28

SABCS 2023 Insights: "ctDNA Monitoring of ER+/HER2- High Risk Breast…

Insights from 2023 SABCS

L. Pusztai

1.6K views
08:41

SABCS 2023 Insights: "Analysis of ctDNA for the Detection of MRD Usi…

Insights from 2023 SABCS

W. Janni

844 views
15:13

SABCS 2023 Insights: "5-Year Outcomes of the IDEA Trial - ET Without…

Insights from 2023 SABCS

R. Jagsi

509 views
03:37

SABCS 2023 Summary: "Is There a Role for Purely Adjuvant IO in Early…

Insights from 2023 SABCS

S. Tolaney, H. Rugo

430 views
14:01

SABCS 2023 Summary: "Is There a Role for IO in Early Stage High Risk…

Insights from 2023 SABCS

S. Tolaney, H. Rugo

565 views
10:27

SABCS 2023 Summary: "What Is the Role for CDK 4/6i in the Adjuvant e…

Insights from 2023 SABCS

S. Tolaney, H. Rugo

1.5K views
08:54

SABCS 2023 Summary: "What Is the Appropriate 1L Therapy for Patients…

Insights from 2023 SABCS

S. Tolaney, H. Rugo

473 views
12:35

SABCS 2023 Summary: "What Is the Appropriate 1L Therapy for ER+ mBC?"

Insights from 2023 SABCS

S. Tolaney, H. Rugo

3.0K views
04:18

SABCS 2023 Insights: "Comparison of NGS Results From the Cerebrospin…

Insights from 2023 SABCS

L. Huppert

261 views
05:48

SABCS 2023 Insights: "Sequential Use of ADCs T-DXd & SG in Patients …

Insights from 2023 SABCS

L. Huppert

212 views
09:19

SABCS 2023 Insights: "Biology or Stage? Tailoring Treatment for Prem…

Insights from 2023 SABCS

K. Kalinsky

1.8K views
03:04

SABCS 2023 Insights: "The Future of Oral SERDs in Breast Cancer"

Insights from 2023 SABCS

E. Hamilton

436 views
03:03

SABCS 2023 Insights: "CAMBRIA 1 Study of Extended Adjuvant Therapy W…

Insights from 2023 SABCS

E. Hamilton

367 views
02:27

SABCS 2023 Insights: "HER2CLIMB-05 Trial - Tucatinib or Placebo in C…

Insights from 2023 SABCS

E. Hamilton

262 views
04:03

SABCS 2023 Insights: "DEBBRAH Study - Trastuzumab Deruxtecan in Pati…

Insights from 2023 SABCS

M. Vaz Batista

177 views
17:35

SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HER2CLIMB-0…

Insights from 2023 SABCS

P. Tarantino

1.1K views
10:56

SABCS 2023 Insights: "CompassHER2 RD Trial - Postneoadjuvant T-DM1 +…

Insights from 2023 SABCS

C. O'Sullivan

304 views
05:40

SABCS 2023 Insights: "CONFIDENT-B Trial - Clinical Implementation of…

Insights from 2023 SABCS

C. Dooijeweert

237 views
07:01

SABCS 2023 Insights: "Clinical Risk Score to Predict Overall Surviva…

Insights from 2023 SABCS

S. Yang

708 views
12:48

SABCS 2023 Insights: "POSITIVE Trial - Fertility Preservation and As…

Insights from 2023 SABCS

H. Azim

205 views
13:01

SABCS 2023 Insights: "Final iDFS Analysis From the NATALEE Trial - R…

Insights from 2023 SABCS

G. Hortobagyi

486 views
09:46

SABCS 2023 Insights: "ELEVATE Study Evaluating Elacestrant in Variou…

Insights from 2023 SABCS

H. Rugo

142 views
14:15

SABCS 2023 Insights: "KEYLYNK-009 Study - Pembro + Olaparib vs. Pemb…

Insights from 2023 SABCS

H. Rugo

321 views
08:24

SABCS 2023 Insights: "PROs From the CAPItello-291 Trial Investigatin…

Insights from 2023 SABCS

H. Rugo

606 views
26:50

SABCS 2023 Insights: "Controversies in the Surgical Management of In…

Insights from 2023 SABCS

A. Lucci

162 views
04:09

SABCS 2023 Insights: "APHINITY Trial - The Benefit of Adjuvant Pertu…

Insights from 2023 SABCS

E. Agostinetto

293 views
14:59

SABCS 2023 Insights: "NRG Oncology/NSABP B-51/RTOG 1304 Trial - Loco…

Insights from 2023 SABCS

T. Mamounas

1.1K views
12:50

SABCS 2023 Insights: "5-Year Clinical Outcomes of ECOG-AGRIN 4112 Tr…

Insights from 2023 SABCS

S. Khan

186 views
04:35

SABCS 2023 Insights: "VIKTORIA-1 Study of Gedatolisib + Fulvestrant …

Insights from 2023 SABCS

S. Hurvitz

298 views
09:52

SABCS 2023 Insights: "HER2CLIMB-02 Trial of Tucatinib & Trastuzumab …

Insights from 2023 SABCS

S. Hurvitz

348 views